Dupilumab in Persistent Asthma with Elevated Eosinophil Levels

Author:

Wenzel, S. [etal]

Publisher:

New England Journal of Medicine

Date published:

2013

Record type:

Journal article

Journal Title:

The New England Journal of Medicine

Source:

The New England Journal of Medicine, Vol. 368, No. 26, June 26, 2013, pp. 2455-2466

Subject:

ASTHMA

PERSISTENT ASTHMA

DUPILUMAB

Abstract:

Patients receiving a long-acting beta-agonist (LABA) and inhaled glucocorticoid for asthma were given dupilumab, a monoclonal antibody to part of the IL-4 receptor, with the LABA and inhaled glucocorticoid withdrawn. There were fewer exacerbations with dupilumab than with placebo.

Language:

English

Catagory URL:

http://www.nejm.org

CITATION: Wenzel, S. [etal]. Dupilumab in Persistent Asthma with Elevated Eosinophil Levels . : New England Journal of Medicine , 2013. The New England Journal of Medicine, Vol. 368, No. 26, June 26, 2013, pp. 2455-2466 - Available at: https://library.au.int/dupilumab-persistent-asthma-elevated-eosinophil-levels-4